Factors determining outcome after third line chemotherapy for metastatic breast cancer
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference33 articles.
1. Global cancer statistics in the year 2000;Parkin;Lancet Oncol,2001
2. Can we cure limited metastatic breast cancer?;Hortobagyi;J Clin Oncol,2002
3. The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s;Cold;Eur J Cancer,1993
4. Improved survival of patients with metastatic breast cancer receiving combination chemotherapy;Ross;Cancer,1985
5. Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer;Stockler;Cancer Treat Rev,2000
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial;Investigational New Drugs;2021-10-11
2. Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program;The Breast;2021-04
3. The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice;Critical Reviews in Oncology/Hematology;2020-09
4. Prior Treatment Time Affects Survival Outcomes in Metastatic Breast Cancer;JCO Clinical Cancer Informatics;2020-09
5. Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer;Acta Oncologica;2020-03-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3